Significance of positive peritoneal cytology for recurrence and survival in patients with endometrial cancer
- 9 October 2022
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (1) , 304-313
Abstract
Aim: This study aims to examine the association between malignant peritoneal cytology and prognosis in women with endometrial cancer.Methods: We retrospectively analyzed the records of patients with endometrial cancer who underwent surgery with intraoperative peritoneal cytology at our hospital between January 1988 and December 2012. All results were reclassified according to the 2009 International Federation of Gynecology and Obstetrics (FIGO) system, and the relation between intraoperative peritoneal cytology results and recurrence and prognosis was examined.Results: Of the 908 patients analyzed, 205 (22.6%) had positive peritoneal cytology. Patients with positive peritoneal cytology had significantly lower rates of recurrence‐free survival (RFS) and overall survival (OS) than those in the negative cytology group (both p < 0.001). Subgroup analysis of patients with FIGO stage I/II showed significantly lower RFS in the positive‐cytology group (p = 0.005), but there was no significant difference in OS (p = 0.637). In the patients with FIGO stage III/IV or patients classified as “high risk,” the RFS and OS were significantly lower in the positive‐cytology group (both p < 0.001). Cox regression analysis identified positive peritoneal cytology as a significant predictor of recurrence in patients with FIGO stage I/II disease.Conclusions: Patients with positive peritoneal cytology for endometrial cancer have a high risk of recurrence, regardless of histopathologic type or FIGO stage. Peritoneal cytology has already been removed from the 2009 FIGO classification of endometrial cancer, but it may deserve reconsideration.Keywords
This publication has 28 references indexed in Scilit:
- Controversies in the Management of Endometrial Carcinoma: An UpdateObstetrics and Gynecology International, 2012
- Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 editionInternational Journal of Clinical Oncology, 2010
- International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer?Journal of Gynecologic Oncology, 2009
- The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinomaJournal of Cancer Research and Clinical Oncology, 2008
- Omental metastases in clinical stage I endometrioid adenocarcinomaInternational Journal of Gynecological Cancer, 2007
- Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysisAnnals of Oncology, 2007
- Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?Gynecologic Oncology, 2006
- Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapyInternational Journal of Gynecological Cancer, 2005
- Positive Peritoneal Cytology in Endometrial Cancer: Enhancement of Other Prognostic IndicatorsGynecologic Oncology, 2001
- The clinical significance of malignant peritoneal cytology in stage I endometrial carcinomaInternational Journal of Gynecological Cancer, 1992